Does MOMETASONE FUROATE Cause Lung opacity? 124 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 124 reports of Lung opacity have been filed in association with MOMETASONE FUROATE (Mometasone Furoate). This represents 1.1% of all adverse event reports for MOMETASONE FUROATE.
124
Reports of Lung opacity with MOMETASONE FUROATE
1.1%
of all MOMETASONE FUROATE reports
0
Deaths
118
Hospitalizations
How Dangerous Is Lung opacity From MOMETASONE FUROATE?
Of the 124 reports, 118 (95.2%) required hospitalization, and 1 (0.8%) were considered life-threatening.
Is Lung opacity Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for MOMETASONE FUROATE. However, 124 reports have been filed with the FAERS database.
What Other Side Effects Does MOMETASONE FUROATE Cause?
No adverse event (3,717)
Product quality issue (3,406)
Poor quality device used (2,159)
Drug dose omission (2,005)
Dyspnoea (1,522)
Device malfunction (1,332)
Asthma (1,307)
Wheezing (1,142)
Cough (1,052)
Gastrooesophageal reflux disease (1,029)
What Other Drugs Cause Lung opacity?
ALBUTEROL (296)
PREDNISONE (216)
TIOTROPIUM (196)
LANSOPRAZOLE (166)
IPRATROPIUM (157)
ACETAMINOPHEN (153)
MEPOLIZUMAB (149)
PANTOPRAZOLE (140)
BUDESONIDE\FORMOTEROL (139)
MONTELUKAST (137)
Which MOMETASONE FUROATE Alternatives Have Lower Lung opacity Risk?
MOMETASONE FUROATE vs MOMETASONE FUROATE\OLOPATADINE
MOMETASONE FUROATE vs MONOMETHYL
MOMETASONE FUROATE vs MONTELUKAST
MOMETASONE FUROATE vs MONTELUKAST\MONTELUKAST
MOMETASONE FUROATE vs MONTMORILLONITE